Medical expenditures associated with major depressive disorder among privately insured working-age adults with diagnosed diabetes in the United States, 2008

Diabetes Research and Clinical Practice

Volumn 100, Issue 1, 2013, Pages 102-110

  Shrestha, Sundar S ^a   Zhang, Ping ^a   Li, Rui ^a   Thompson, Theodore J ^a   Chapman, Daniel P ^a   Barker, Lawrence ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antidepressant medication; Depression; Insulin; Insulin treated diabetes; Medical costs

Indexed keywords

ANTIDEPRESSANT AGENT; INSULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CEREBROVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT; PRESCRIPTION; PRIVATE HEALTH INSURANCE; RESIDENTIAL AREA; RHEUMATIC DISEASE; SEX DIFFERENCE; UNITED STATES;

AGE DISTRIBUTION; ANTIDEPRESSIVE AGENTS; COMORBIDITY; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; FEMALE; FINANCING, PERSONAL; HEALTH CARE COSTS; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; SEX DISTRIBUTION; TIME FACTORS; UNITED STATES;

EID: 84876739973     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.02.002     Document Type: Article

References (32)

1. Egede L.E., Ellis C. Diabetes and depression: global perspectives. Diabetes Res Clin Pract 2010, 87(3):302-312.
2. Li C., Ford E.S., Strine T.W., Mokdad A.H. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care 2008, 31(1):105-107.
3. American Diabetes Association Standards of medical care in diabetes-2012. Diabetes Care 2012, 35(Suppl. 1):S11-S63.
4. Das-Munshi J., Stewart R., Ismail K., Bebbington P.E., Jenkins R., Prince M.J. Diabetes, common mental disorders, and disability: findings from the UK National Psychiatric Morbidity Survey. Psychosom Med 2007, 69(6):543-550.
5. Egede L.E., Zheng D., Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002, 25(3):464-470.
6. Subramaniam M., Sum C.F., Pek E., Stahl D., Verma S., Liow P.H., et al. Comorbid depression and increased health care utilisation in individuals with diabetes. Gen Hosp Psychiatry 2009, 31(3):220-224.
7. Vamos E.P., Mucsi I., Keszei A., Kopp M.S., Novak M. Comorbid depression is associated with increased healthcare utilization and lost productivity in persons with diabetes: a large nationally representative Hungarian population survey. Psychosom Med 2009, 71(5):501-507.
8. Le T.K., Curtis B., Kahle-Wrobleski K., Johnston J., Haldane D., Melfi C. Treatment patterns and resource use among patients with comorbid diabetes mellitus and major depressive disorder. J Med Econ 2011, 14(4):440-447.
9. Finkelstein E.A., Bray J.W., Chen H., Larson M.J., Miller K., Tompkins C., et al. Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 2003, 26(2):415-420.
10. Simon G.E., Katon W.J., Lin E.H.B., Ludman E., VonKorff M., Ciechanowski P., et al. Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry 2005, 27(5):344-351.
11. Lin E.H., Rutter C.M., Katon W., Heckbert S.R., Ciechanowski P., Oliver M.M., et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010, 33(2):264-269.
12. de Groot M., Jacobson A.M., Samson J.A., Welch G. Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res 1999, 46(5):425-435.
13. Manarte L.F., Dias S., Gois C., Boavida J.M. Independent factors associated with depression in type 1 diabetes mellitus. Acta Diabetol 2010, 47(3):201-207.
14. Makine C., Karsidag C., Kadioglu P., Ilkova H., Karsidag K., Skovlund S.E., et al. Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with Type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research Consortium. Diabet Med 2009, 26(1):28-33.
15. Aikens J.E., Perkins D.W., Lipton B., Piette J.D. Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes. Diabetes Care 2009, 32(7):1177-1181.
16. Gonzalez J.S., Safren S.A., Cagliero E., Wexler D.J., Delahanty L., Wittenberg E., et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007, 30(9):2222-2227.
17. Hutter N., Schnurr A., Baumeister H. Healthcare costs in patients with diabetes mellitus and comorbid mental disorders-a systematic review. Diabetologia 2010, 53(12):2470-2479.
18. Hensen L.G., Chang S. Health research rata for the real world: The Thompson Reuters Marketscan Databases. White paper 2010, Thompson Reuters, Ann Arbor, MI, 1-28.
19. Thomson Medstat. MarketScan (R) Research Databases User Guide and Database Dictionary: Commercial Claims and Encounters Medicare Supplemental and COB, 2005 Edition, Thomson Medstat. Ann Arbor, MI.
20. Shrestha S.S., Zhang P., Albright A., Imperatore G. Medical expenditures associated with diabetes among privately insured U.S. youth in 2007. Diabetes Care 2011, 34(5):1097-1101.
21. Gibson T.B., Jing Y., Smith Carls G., Kim E., Bagalman J.E., Burton W.N., et al. Cost burden of treatment resistance in patients with depression. Am J Manag Care 2010, 16(5):370-377.
22. Hellinger F.J., Encinosa W.E. The cost and incidence of prescribing errors among privately insured HIV patients. Pharmacoeconomics 2010, 28(1):23-34.
23. Cohen F.J., Neslusan C.A., Conklin J.E., Song X. Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes. Diabetes Care 2003, 26(6):1847-1851.
24. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45(6):613-619.
25. Diehr P., Yanez D., Ash A., Hornbrook M., Lin D.Y. Methods for analyzing health care utilization and costs. Annu Rev Public Health 1999, 20:125-144.
26. Manning W.G., Mullahy J. Estimating log models: to transform or not to transform?. J Health Econ 2001, 20(4):461-494.
27. Cutler D.M., McClellan M., Newhouse J.P. How does managed care do it?. Rand J Econ 2000, 31(3):526-548.
28. Bogner H.R., Morales K.H., de Vries H.F., Cappola A.R. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Annals of Family Medicine 2012, 10:15-22.
29. Katon W., Unutzer J., Fan M.Y., Williams J.W., Schoenbaum M., Lin E.H., et al. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 2006, 29(2):265-270.
30. Katon W.J., Russo J.E., Von Korff M., Lin E.H.B., Ludman E., Ciechanowski P.S. Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes. Diabetes Care 2008, 31(6):1155-1159.
31. Simon G.E., Katon W.J., Lin E.H.B., Rutter C., Manning W.G., Von Korff M., et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry 2007, 64(1):65-72.
32. Li C., Ford E.S., Zhao G., Ahluwalia I.B., Pearson W.S., Mokdad A.H. Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the Behavioral Risk Factor Surveillance System, 2006. Diabetes Res Clin Pract 2009, 83(2):268-279.